Hypertension in women: is inflammation the key?

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

10.1161/01.cir.98.8.731 · 1998

C-reactive protein and the risk of developing hypertension

10.1001/jama.290.22.2945 · 2003

Inflammation and the long-term incidence of hypertension in women

10.1093/eurjpc/zwag426

Sex differences in arterial hypertension

10.1093/eurheartj/ehac470 · 2022

Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study

10.1093/eurjpc/zwab068 · 2022

Effects of interleukin-1β inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS

10.1161/hypertensionaha.119.13642 · 2020

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

10.1016/s0140-6736(22)01349-6 · 2022

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

10.1136/ard.2009.124180 · 2010

Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)